Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor

Laprairie, R B, Bagher, A M, Kelly, M E M, Denovan‐Wright, E M·2015·British Journal of Pharmacology
DOI 10.1111/bph.13250

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Efficacy and Safety Profile of Cannabinoid-targeted Compounds for Seizure Control in Immature Animals
    Megan N. Huizenga · 2018 · DigitalGeorgetown (Georgetown University Library)
  2. Le cannabis, son Δ9-tétrahydrocannabinol/THC et le système endocannabinoïde
    Jean Costentin · 2020 · La Presse Médicale Formation
  3. Efectos del consumo de Omegas 6 y 3 sobre los niveles de ácido araquidónico y su asociación con la adicción a la comida en adultos obesos: Un estudio piloto
    Morales Basto, Juan Pablo · 2020
  4. Circadian Medicine: Cannabinoid Chronotherapy for Treatment of Hypertension
    Aidan Murray · 2020 · The Atrium (University of Guelph)
  5. CHARACTERIZATION AND TARGETING OF THE ENDOCANNABINOID SYSTEM IN TRAUMATIC BRAIN INJURY
    Tallan Black · 2020 · HARVEST (University of Saskatchewan)
  6. Neuroprotective Effects of Cannabidiol Following Concussion: A Case Study
    Jyotpal Singh · 2019 · oURspace (University of Regina)
  7. Effects of Cannabis Abstinence on Symptoms and Cognition in Major Depressive Disorder
    Aliya M. Lucatch · 2019 · TSpace (University of Toronto)
  8. 3-year Outcomes of Cannabis use Patterns: Evidence from a Longitudinal Survey
    Tongtong Chen · 2019 · TSpace (University of Toronto)
  9. Análise teórica da atuação de canabinoides nas vias metabólicas do câncer de mama por meio da biologia de sistemas e revisão sistemática da literatura
    JONATAN TELLES RAMOS, Scheila De Avila E Silva, Vanessa Lins Lemos · 2021 · SaBios-Revista de Saúde e Biologia
  10. An Investigation into the Molecular Targets Mediating Cannabidiol Action in the Free-living Ciliate Tetrahymena pyriformis
    Nathan Tims · 2021 · Lancaster EPrints (Lancaster University)
  11. Insights into the Molecular Role of Endocannabinoids in Diabetes Mellitus
    2021 · Biointerface Research in Applied Chemistry
  12. G protein-coupled receptor (GPCR)-dependent transduction
    Haley K. Andersen, Robert B. Laprairie · 2022 · Elsevier eBooks
  13. O efeito da exposição pré-natal ao Canabidiol na facilitação do Status Epilepticus pós-natal
    Jórdan Fares Sampar · 2021
  14. Neuroscience
    Godfrey D. Pearlson · 2020 · Elsevier eBooks
  15. Cannabidiol (CBD) drives sex-dependent impairments in omission, but has no effect on reinforcer devaluation
    Caroline Morehouse, C. Maddox, Rochelle K. van der Merwe, Robert McLaughlin, Jesse R. Scott, Marwan M. Ghanem, Eric S. Ramsson, Christopher D. Howard · 2022 · Behavioural Brain Research
  16. An insight into the acute effects of cannabidiol on human brain function and their relationship with the brain expression of its molecular targets: a neuroimaging meta-regression analysis
    Brandon Gunasekera, Cathy Davies, Grace Blest‐Hopley, Robin Paul Wilson, Geraldo F. Busatto, José Alexandre S. Crippa, Fábio Duran, Antônio Waldo Zuardi, Mattia Veronese, Joaquim Raduà et al. · 2022 · Research Square
  17. Molecular mechanisms underlying cannabis-induced risk of psychosis
    Paula Unzueta‐Larrinaga, Luis Felipe Callado, Leyre Urigüen · 2022 · Elsevier eBooks
  18. Canabidiol em modelo pré-clínico de dor neuropática: uma avaliação dos aspectos sensoriais, emocionais e inflamatórios relacionados com a modulação da sensibilidade dolorosa
    Gleice Kelli Ribeiro da Silva Cardoso · 2022
  19. Application of cannabidol to ocular pharmacokinetics and pharmacodynamics.
    Alyssa S. Laun · 2022
  20. Cannabidiol for people with schizophrenia
    Diana Buitrago‐García, Guillermo Sánchez, Paula Alejandra Sánchez Correa, Stela del pilar Baracaldo, Santiago Felipe Gallego Gallego, Lone Baandrup · 2022 · Cochrane Database of Systematic Reviews
  21. Occupational Considerations Related to Cannabis Use
    Gregory Lawson Smith · 2022 · Springer eBooks
  22. Phytocannabinoids and synthetic cannabinoids – pharmacotherapeutic aspects
    Nicoleta Mirela Blebea · 2023 · Farmacist ro
  23. Features of (+)-trans-cannabidiol-2-hydroxy pentyl and applications to disease: A focus on usage in diabetic nephropathy
    Eduardo Muñóz, Matthias Winkler, Marcus Rudolf Götz, Isabel González‐Mariscal · 2023 · Elsevier eBooks
  24. Brain metabolic responses to cannabis use in people with multiple sclerosis: Insights from [18F]-FDG positron emission tomography and functional MRI
    Thorsten Rudroff, Craig David Workman · 2023 · Elsevier eBooks
  25. Community Series - Purple Haze: Issues on Cannabis Legalization, volume II
    2023 · Frontiers research topics
  26. O uso de cannabis medicinal no tratamento de transtornos por uso de opioides: Uma revisão sistemática
    Augusto Mendes Ferreira, Jullyana Sarah Magalhães Silva, Kaio Figueiredo da Silva Cruz, Marycassiely Rodrigues Tizolim, Washington Luiz Aquino de Souza, Gabrielle Mendes Lima · 2023 · Research Society and Development
  27. Efectos terapéuticos del Cannabidiol en la epilepsia: un estudio preclínico en el modelo animal de epilepsia audiogénica GASH/Sal
    Giselda Cabral-Pereira · 2023
  28. Effects of Cannabis Exposure on Adolescent Health and Development: A Narrative Review
    R. L. Li, Feng Tao · 2024 · Current Drug Research Reviews
  29. Medical Use of Cannabinoids and Psychedelic Compounds
    Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi · 2023 · Springer eBooks
  30. Cannabis use associated with lower mortality among hospitalized Covid-19 patients using the national inpatient sample: an epidemiological study
    Joseph Igwe, Ugo Alaribe · 2024 · Journal of Cannabis Research
  31. Biological fate of cannabis and its metabolic products
    Raja Babu, Abhipsa Mohapatra, Amarjeet Amarjeet, Debapriya Garabadu · 2024 · Elsevier eBooks
  32. Komplementärmedizinische Verfahren in der Rheumatologie
    Gernot Keyßer, Inna Frohne, Olaf Schultz, Monika A Reuss-Borst, Oliver Sander, Alexander Pfeil · 2024 · Zeitschrift für Rheumatologie
  33. Aplicabilidade da Cannabis e seus derivados no manejo da dor crônica
    Emmanuel De Oliveira Carneiro, Bruna Rossi, Adriana Lopes de Freitas, Francisco José Germano Hennemann, Giovanna Rangel dos Santos, Hermes Castro de Araujo, Maraísa do Nascimento · 2024 · Revista Cereus
  34. Cannabis in anticancer drug development
    Ernest Matambo, Andrew Glory Mtewa, Tadala Mzengo, Muhammad Riaz · 2024 · Elsevier eBooks
  35. In vivo and in vitro assays, and safety profiles of cannabinoids
    Mayeso N.V. Gwedela, Collins Edward Jana, Tuntufye Mwambyale, Ibrahim Chikowe, Lifa Chimphepo, George Chirambo · 2024 · Elsevier eBooks
  36. Cannabidiol enhances socially transmitted food preference: a role of acetylcholine in the mouse basal forebrain
    Chih-Yu Chang, Wen Dai, Sherry Shu‐Jung Hu · 2024 · Psychopharmacology
  37. Medical Use of Cannabinoids and Psychedelic Compounds
    Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi · 2024 · Springer eBooks
  38. Principais alvos farmacológicos e potencial terapêutico do canabidiol (CDB)
    Ana Beatriz Monteiro de Medeiros, Laíza Andrade Soares Diniz, Aarão Gonçalves de Lira, Isabelle Teixeira Zambrzycki, Sara Calumbi Nachipindo Kawalende, Iara de Sousa Alves, Laura Oliveira Lorenzo de Andrade, Tiago Marinho Barbalho, Avanúzia Ferreira Matias, Edna da Silva Costa et al. · 2024 · Caderno Pedagógico
  39. Chronic Pain Management after Necrotizing Soft Tissue Infection (NSTI): A Case Report
    Kinyungu Njoroge, Vivian Matubia, Ngugi M. Kinyungu · 2024 · Case Reports in Clinical Medicine
  40. O USO DO CANABIDIOL NO TRATAMENTO DO TRANSTORNO OBSESSIVO COMPULSIVO
    Lorena Alexia de Araujo, Marina da Lus, Ligia dos Santos Mendes Lemes Soares · 2024 · Revista Foco
  41. The Role of Cannabinoids and the Endocannabinoid System in the Treatment and Regulation of Nausea and Vomiting
    Erin M. Rock, Linda A. Parker · 2024 · Current topics in behavioral neurosciences
  42. Multiple casualty poisoning event in dogs after exposure to synthetic drugs of abuse in a public park
    Vasiliki Karadima, Poppy Sharpley, Andre Brenn, Shannon Ward, Nicola Bates · 2025 · Veterinary Record Case Reports
  43. Die Pharmakologie der Cannabinoide
    Greg Copas, Erik de Almeida Amazonas, Sarah Brandon · 2024 · Springer eBooks
  44. Molecular mechanisms and pharmacology of cannabinoids: from theory to practice
    Marek Lapka · 2025 · Klinická farmakologie a farmacie
  45. Cannabis sativa: A Review on Recent Patents and Advancements for Human Health
    Chanchal Rani, Nikita Kaushik, Prity Sharma, Chetna, Preeti Dahiya, Kaushal Arora, Etash Vashisht · 2025 · Current Bioactive Compounds
  46. Overview of the Endogenous Cannabinoid Signaling System
    Todd M. Stollenwerk, César E. Martinez Ramirez, Cecilia J. Hillard · 2025 · Springer eBooks
  47. Pharmacoepigenetics of cannabis and cannabinoids
    Anna Starnawska, Lucas Holdgaard Ørskov, Qvist Per, Joca Sâmia · 2025 · Elsevier eBooks
  48. Geospatiotemporal and causal inferential epidemiological survey and exploration of cannabinoid- and substance-related carcinogenesis in USA 2003–2017
    Albert Stuart Reece, Gary Kenneth Hulse · 2025 · Elsevier eBooks
  49. Implications for policy
    2025 · Elsevier eBooks
  50. Sex differences in the capacity of minor phytocannabinoids to attenuate nociceptive insults in HIV-1 Tat-expressing mice
    Alaa N. Qrareya, Emaya M. Moss, Fakhri Mahdi, Mohammed Salahuddin, Duoyi Hu, Miguel A. De Leon, Amira S. Wanas, Mohamed M. Radwan, Mahmoud A. ElSohly, Nicole M. Ashpole et al. · 2025 · NeuroImmune Pharmacology and Therapeutics
  51. Identification of Tetrahydrocannabidiol Metabolites in Human Urine
    Willi Schirmer, Isabelle Mösch, Stefan Schürch, Wolfgang Weinmann · 2025 · Drug Testing and Analysis
  52. UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome
    Lilia Evans, Simon Erridge, Madhur Varadpande, Arushika Aggarwal, Isaac Cowley, Eleanor Clarke, Katy McLachlan, Ross Coomber, James Rucker, Michael W. Platt et al. · 2025 · Brain and Behavior
  53. Opposing Synovial Cannabinoid Receptor Type 2 and Transient Receptor Potential Vanilloid 1 Expression in Painful Osteoarthritis
    Collin A Toups, Lauren G Guillot, Kaitlyn Redondo, Sydney Jensen, Jennifer Klein, Luis Marrero · 2025 · Cureus
  54. Carvone derived cannabidiol enantiomers as novel anticonvulsants
    Rochelle M. Hines, April Contreras, Adriana Carrillo, Alexandra Paton, Antonio J. Tenorio, William A. Maio, Dustin J. Hines · 2025 · Neuropsychopharmacology
  55. In silico insights on the binding site and function of cannabinoids and cannabinoid acids on human 5-HT1A receptor
    Beow Keat Yap, Scott Palmer, Thomas Piccariello · 2025 · Journal of Molecular Graphics and Modelling
  56. The Pharmacological Profile of Plant-Derived Cannabinoids In Vitro
    S P H Alexander · 2025 · Current topics in behavioral neurosciences
  57. Acute Effects of Cannabis and THC Oils on Cardiovascular Hemodynamics and Muscle Electrical Activity in Healthy Individuals: A Controlled Clinical Crossover Trial Protocol
    Marina Lyra Lima Cabral Fagundes, Edna Karla Ferreira Laurentino, Bruno Lobão Soares, Matías Otto‐Yáñez, Emerson Arcoverde Nunes, Matheus de Freitas Fernandes‐Pedrosa, Jéssica Danielle Medeiros da Fonsêca, Vanessa Resqueti, Guilherme Fregonezi · 2025 · Journal of Clinical Medicine
  58. Cannabis sativa extracts reduce inclusion formation in a cell model of alpha-synuclein aggregation
    Tamires de Almeida Cruz, Rodrigo de Paulo Osorio, Neide Mara de Menezes Epifânio, Madiha Mohieldin Merghani, Marcos Dias Pereira, Douglas Siqueira de Almeida Chaves, Tiago F. Outeiro, Cristiano Jorge Riger · 2025 · Fitoterapia
  59. Endocannabinoids in pain modulation
    Victoria Chapman, Stephen George Woodhams · 2025 · Handbook of behavioral neuroscience
  60. Cellular effects of endocannabinoids in the CNS
    Ken Mackie, Beat Lutz · 2025 · Handbook of behavioral neuroscience
  61. Can Endocannabinoids Explain CBD-Mediated Reduction in Blood Pressure? Insights from a Randomized, Placebo-Controlled, Crossover Trial
    Marko Kumrić, Goran Dujić, Josip Vrdoljak, Daniela Šupe‐Domić, Željko Dujić, Joško Božić · 2025 · Cannabis and Cannabinoid Research
  62. The Pharmacokinetic and Pharmacodynamic Drug-drug Interaction Potential of Cannabidiol
    Guillermo Alberto Keller, Jorge Alejandro Aimar · 2025 · Drug Metabolism and Bioanalysis
  63. Cannabidiol modulates classical and non-classical HLA expression in human choriocarcinoma cell line
    Kevin Martinez, María B. Palma, Fernando J. Sepúlveda, Edgardo Delfino Carosella, Marcela Nilda García, F.L. Riccillo · 2026 · Human Immunology
  64. FIGURES 45. Axinyssa djiferi spec. nov. 4 in A new species of Axinyssa Lendenfeld, 1897 (Porifera, Demospongiae, Halichondrida) from the Senegalese coast
    Nicole Boury‐Esnault, Christian Marschal, Probst, Jean-Michel Korn-, Gilles Barnathan · 2002 · INFM-OAR (INFN Catania)
  65. Additional file 6 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  66. Additional file 3 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  67. Additional file 1 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  68. Additional file 4 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  69. Additional file 1 of Cannabis use associated with lower mortality among hospitalized Covid-19 patients using the national inpatient sample: an epidemiological study
    Joseph Igwe, Ugo Alaribe · 2024 · Figshare
  70. Additional file 5 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  71. Additional file 1 of Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis
    Christopher Failing, Boehnke, Kevin F., Meredith P. Riebschleger · 2021 · Figshare
  72. Additional file 2 of Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications
    Ainhoa Bilbao, Spanagel, Rainer · 2022 · Figshare
  73. The Effect of Cannabidiol on Nociceptive Behaviour and the Endocannabinoid System in an Incisional Wound Model
    Maria C. Redmond, Catherine R. Healy, Mary A. Hopkins, Rosmara Infantino, Georgina Gethin, Abhay S. Pandit, David P. Finn · 2025 · Pharmaceuticals
  74. Cannabidiol–Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma
    Marí­a de Guadalupe Chávez-López, Arturo Ávalos‐Fuentes, Estrella del C. Cruz-Manzo, Pedro A. Aguirre-Arriaga, Benjamí­n Florán, Julio Isael Pérez‐Carreón, Cecilia Bañuelos, Javier Camacho · 2026 · Pathophysiology
  75. Vaping Δ 9 -tetrahydrocannabinol (Δ 9 -THC) in liquid forms: pharmacokinetics, pharmacodynamics, and regulatory implications
    Block Aw, Danielle M. Smith, Maciej Lukasz Goniewicz · 2026 · Expert Review of Clinical Pharmacology
  76. Emerging Cannabidiol Research in Neurological Disorders: Insights into Epilepsy, Multiple Sclerosis, and Depression
    Juwon kim · 2026 · International journal of high school research
  77. Modulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies
    Gabriel P. A. Costa, Mayte A Cerezo-Matias, Melissa Christine Funaro, Deniz Bağdaş, Alfred P. Kaye, John Harrison Krystal, Ismene L. Petrakis, João Paulo De Aquino · 2026 · Molecular Psychiatry
  78. A single dose of cannabidiol increases ad libitum energy intake in healthy adults but does not affect postprandial glucose or lipid metabolism
    Drusus A. Johnson, Mark P. Funnell, Thomas G. Cable, Donald L. Peden, Chris J. McLeod, Patrick Crane Wheeler, Stephen J. Bailey, Tom Clifford, Liam M. Heaney, Lewis John James · 2026 · Appetite
  79. Cannabidiol Mitigates Ketamine-Induced Hyperlocomotion Via Allosteric Potentiation of Ventral Tegmental Glycine Receptor α1 Signaling
    Xianglian Wang, Jing Xia, Heyi Luo, Huanhuan Mao, Dongyang Wang, Jin Jin, Wei Xiong · 2026 · Biological Psychiatry
  80. Radical Revelations: The Interplay of Nitrosative Stress, the Endocannabinoid System, and Treatment of Age-Related Disorders
    Avery Davis, Isabella Y. Casmedes, Michael D. Burton · 2026 · International Journal of Molecular Sciences
  81. Cannabinoids and cognition in Parkinson’s disease: Insights from animal models and emerging clinical evidence
    Valentina F. Kitchigina, Liubov Shubina · 2026 · Neuroscience
  82. From Flower to Function: Medical Cannabis Modalities in Orthopedic Practice
    Chris Sun, Anthony Castro, Sina Ramtin · 2026 · SurgiColl
  83. Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2 deletion syndrome (ZYN2-CL-031)
    Helen Heussler, Jonathan Cohen, Caroline B. Buchanan, David S. Albers, Kristen G Bzdek · 2026 · Journal of Neurodevelopmental Disorders
  84. Targeting Phantom Limb Pain with Cannabinoids in a Rat Model
    Anjalika Eeswara, Kristin Perrucci, Stanislava Jergová, Jacqueline Sagen · 2026 · Medical Cannabis and Cannabinoids
  85. Cannabinoid exposure during pregnancy: Cardiorespiratory effects and offspring outcomes
    Luís Gustavo A. Patrone, Luciane H. Gargaglioni · 2026 · The Journal of Physiology
  86. Place preference in a female adolescent rat model of neuropathic pain: The effects of cannabidiol and oxycodone on cerebellum cell density
    Crystal N. Li, Samantha Warren, Elaina Vlassopoulos, Marissa Sgro, Sydney Harris, Luke A. Henderson, Kevin A. Keay, Richelle Mychasiuk · 2026 · Psychopharmacology
  87. Etude des lipides membranaires comme facteur de vulnérabilité à la psychose chez des patients à ultra haut risque de psychose (UHR) et dans un modèle murin
    Ariel Frajerman · 2021 · theses.fr (ABES)
  88. Evaluating the cannabinoid CB1 receptor as a therapeutic target in a Shank3 mouse model of autism and Phelan-McDermid syndrome
    Flavio Tomasi · 2023 · theses.fr (ABES)
  89. UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine
    Lennon Hooper, Simon Erridge, Evonne Clarke, Katy McLachlan, Ross Coomber, Augustin Iqbal, James Rucker, Mark W. Weatherall, Mikael H Sodergren · 2026 · Brain and Behavior
  90. Cannabidiol and diabetic heart disease: Mechanistic evidence and translational challenges
    Afolake Arowolo, Oluyomi Stephen Adeyemı, Toluwalope Esther Ajonijebu, Aminu Musa, Hygon Mutavhatsindi, Rabia Johnson, Kenechukwu Obikeze · 2026 · Biomedicine & Pharmacotherapy
  91. Perinatal cannabidiol exposure reshapes astrocyte morphology and tripartite synapse organization in a sex-dependent manner
    Gabriel H Dias de Abreu, Jeremy Wilson, Vitor Ritzmann, Oscar John Moosbrugger, Clare T. Johnson, Ken Mackie, Heather B. Bradshaw, Jui-Yen Huang, Hui‐Chen Lu · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Cannabidiol at the crossroads: panacea, placebo, or problem?
    L. Cinnamon Bidwell, Ryan G. Vandrey · 2026 · Neuropsychopharmacology
  93. O uso de Canabidiol no tratamento da Doença de Alzheimer: Quais são os principais efeitos farmacológicos atribuídos ao Canabidiol relevantes para o tratamento da Doença de Alzheimer?
    Julia Grazielly dos Santos, Jean Colacite · 2026 · Research Society and Development
  94. Plasma cannabinoid pharmacokinetics following the inhalation of vaporised cannabis with and without cannabidiol
    Daniel Hall, Edward Chesney, Claire Mokrysz, Anna Caldwell, John M. Halket, Kat Petrilli, Matthew B. Wall, H. Valerie Curran, Tom P. Freeman, Will Lawn · 2026 · Drug and Alcohol Dependence
  95. Cannabinoids as a Systemic Modulator of Homeostasis: Modern Biochemical Mechanisms of Action and Clinical Perspectives
    I. SORVILLO, A. S. VOITKIVSKA, M.-A. T. VACHKO, A. M. ZHELIZKO, Ю.М. Федевич · 2026 · Experimental and Clinical Physiology and Biochemistry
  96. Cannabinoids in autoimmune diseases: mechanistic insights and translational challenges
    Yasir Akhtar Khan, Mohammad Anas, Farha Khan, Mubashshir Ali, Mohammed Mousa Al-Zharani, Fahd A. Nasr, Wajhul Qamar, Shakilur Rahman · 2026 · Biochemical Pharmacology
  97. Effects of THC, CBD, and Their Combination on EEG Dynamics in Rats
    Marcel Bochin, Čestmír Vejmola, Vlastimil Koudelka, Stanislav Jiříček, Marek Nikolič, Klára Šíchová, Tomáš Páleníček · 2026 · Physiological Research
  98. O USO DE CANABIDIOL NO TRATAMENTO DA EPILEPSIA IDIOPÁTICA CANINA: REVISÃO DE LITERATURA
    Camille Nitolo Matias, Isabelle Tufano Leite · 2026 · Revista Foco
  99. Cannabidiol for Mucosal Diseases: Therapeutic Potential and Advanced Delivery Strategies
    Bo Han, Y Zhang, Y M Wang, Yue Shen, Jinping Niu, Shipo Li, Yuxi Li, Jingyu Wang, Xingyuan Ma, Wenyun Zheng · 2026 · Pharmaceutics
  100. Synthetic CB1 Modulators in Clinical Trials: A Medicinal Chemistry Review
    Gustavo Manoel Oliveira dos Santos Naziozene, R Parise-Filho · 2026 · ChemMedChem